Blue Heron Capital is a Richmond, Virginia-based growth equity firm focused on healthcare and enterprise technology. Founded in 2006, the firm typically invests in companies with $3 million to $25 million in revenue, taking minority positions to provide growth capital. Blue Heron combines financial capital with the human capital of its OA Collaborative to fund and build businesses.
52% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deals in the last 12 months vs 3 prior). Their most common stage is series-a (40% of deals). Average disclosed round size is $28.1M (across 23 rounds with reported amounts).
Portfolio
23
Fund Size
$102M
Top Stage
Series A
Last 12 Mo
1
Team
Matt Jacobson
Director of Investor Relations
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| TTava | Series C | $40M | Apr 2026 |
 CSA Medical | Series D | $53M | Sep 2024 |
| CCsa Medical Inc | Series D | $53M | Sep 2024 |
 2weeks | Pre-Seed | $1.3M | Aug 2024 |
 Tava Health | Series B | $20M | Mar 2024 |
 ShiftMed | Growth | $200M | Feb 2023 |
 AnswersNow | Series A | $11M | Feb 2023 |
 Yes Hearing | Series A | $10M | Jan 2022 |
 Insightin | Series A | $12M | Feb 2021 |
 Aware | Series C | $60M | Jan 2021 |
 VIDA Diagnostics | Series C | $11M | Mar 2020 |
| Aware | Series B | $12M | Jan 2020 |
 Stratasan | Bridge | — | Jan 2019 |
 ChartSpan | Unknown | $15M | Jan 2019 |
 Verisma | Unknown | $12M | Jan 2015 |
| WWiserTogether | Series B | $9M | Jan 2014 |
 Proof | Series A | $7M | — |
 InsightIn Health | Series A | $12M | — |
 Kion | Series A | $9.5M | — |
| OOgnomy Sleep | Series A | $20M | — |
 Remission Medical | Series A | — | — |
| Tava Health | Series C | $40M | — |
 Proof | Series A | $7M | — |
 Homecare.com | Unknown | $11M | — |
 Ognomy | Series A | $20M | — |
Top Co-Investors
Last updated: 8 September 2026